Sequential therapy or triple therapy for helicobacter pylori infection: Systematic review and meta-analysis of randomized controlled trials in adults and children

American Journal of Gastroenterology

Volumn 104, Issue 12, 2009, Pages 3069-3079

  Gatta, Luigi ^a,b   Vakil, Nimish ^c,d   Leandro, Gioacchino ^b   Di Mario, Francesco ^b   Vaira, Dino ^e  

^a Versilia Hospital   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d MARQUETTE UNIVERSITY   (United States)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; TINIDAZOLE;

ADULT; ADULT DISEASE; ANTIBIOTIC RESISTANCE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TINIDAZOLE;

EID: 72949096113     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.555     Document Type: Review

References (47)

1. Vakil N, Megraud F. Eradication treatment for Helicobacter pylori. Gastroenterology 2007;133:985-1001.
2. Malfertheiner P, Megraud F, O' Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781 (Pubitemid 46854190)
3. Zullo A, De Francesco V, Hassan C et al. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007;56:1353-1357 (Pubitemid 47517826)
4. Moher D, Cook DJ, Eastwood S et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-1900
5. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version, 5.0.0 [updated February 2008] The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org. Accessed 1 August 2008.
6. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
8. Gisbert J, Hermida C, Pajares J. Are 12 days of omeprazole, amoxcillin and clarithromycin better than 6 days for treating H pylori infection in peptic ulcer and non-ulcer dyspepsia. Hepatogastroenterology 2001;48:1383-1388
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
10. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988;7:889-894
11. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634
12. Newcombe RG, Altman DG. Proportion and their differences. In: Altman DG, Machin D, Trevor NB (eds) Statistics with Confidences, 2nd edn BMJ Books: London, 2000, 45-56.
13. Altman DG. Confidence interval for number need to treat. BMJ 1998;317:1309-1312
14. Leandro G. Meta-analysis in Medical Research. BMJ Books: London, 2005.
15. Focareta R, Forte G, Ciarleglio A et al. Helicobacter pylori eradication: one week triple therapy vs. 10-day sequentail regimen introduction. Dig Liver Dis 2002;34 (Suppl 1): A17.
16. Focareta R, Forte G, Forte F et al. Could the 10-days sequential therapy be considered a first choice treatment for the eradication of Helicobacter pylori infection? Dig Liver Dis 2003;35(Suppl 5): S33.
17. Zullo A, Vaira D, Vakil N et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Alimen Pharmacol Ther 2003;17:719-726
18. De Francesco V, Zullo A, Margiotta M et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Alimen Pharmacol Ther 2004;19:407-414
19. De Francesco V, Zullo A, Hassan C et al. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. Dig Liv Dis 2004;36:322-326
20. Zullo A, Scaccianoce G, Hassan C et al. Helicobacter pylori eradication with 7-day triple therapy, 10-day regimen, and sequential therapy. Gut 2004;53 (Suppl VI): A120.
21. Zullo A, Gatta L, De Francesco V et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Alimen Pharmacol Ther 2005;21:1419-1424
22. Francavilla R, Lionetti E, Castellaneta SP et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2005;129:1414-1419
23. Scaccianoce G, Hassan C, Panarese A et al. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. Can J Gastroenterol 2006;20:113-117
24. Lerro P, Kuvidi M, Bladi M et al. A 10-day sequential therapy: new option for Helicobacter pylori eradication in children. Dig Liver Dis 2006;38: A87.
25. Vaira D, Zullo A, Vakil N et al. Sequential therapy versus standard tripledrug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med 2007;146:556-563
26. Hurduc V, Gradomir D, Leseanu G et al. Comparison of sequential and triple therapies in the eradication of H. pylori infection in symptomatic children. Gut 2007;56: A243.
27. Ruiz-Obaldia JR, Torrazza GE, Carreno NO. Helicobacter pylori eradication with either conventional 10 day triple therapy or 10-day modified sequential regimen. Gastroenterology 2008;134: A24.
28. Wu DC, Hsu PI, Wu JY et al. Randomized controlled comparison of sequential and quadruple (concomitant) therapies for H pylori infection. Gastroenterology 2008;134: A24.
29. Paoluzzi OA, Visconti E, Andrei F et al. Sequential regimens have greater and better tolerability than triple therapy in the eradication of Helicobacter pylori infection. Gastroenterology 2008;134: A331.
30. De Francesco V, Zullo A, Hassan C et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liv Dis 2001;33:676-679
31. De Francesco V, Margiotta M, Zullo A et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006;144:94-100. (Pubitemid 46768227)
32. Choi WH, Park DI, Oh SJ et al. Effectiveness of 10 days sequential therapy for Helicobacter pylori eradication in Korea. Korean J Gastroenterol 2008;51:280-284
33. Wu HY, Hui YT, Lam JTW et al. Ten day sequential therapy as the first line eradication of Helicobacter pylori infection in Chinese patients: a randomized controlled trial. Gut 2008;57: A 330.
34. Fuccio L, Minardi M, Zagari R et al. Meta-analysis of first-line proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. Ann Inten Med 2007;147:553-562
35. Vakil N, Lanza F, Schwartz H et al. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther 2004;20:99-107.
36. Katelaris PH, Forbes GM, Talley NJ et al. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology 2002;123:1763-1769
37. Fischbach LA, van Zanten S, Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004;20:1071-1082
38. Zullo A, Perna F, Hassan C et al. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 2007;25:1429-1434 (Pubitemid 46848887)
39. Glocker E, Stueger HP, Kist M. Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother 2007;51:346-349
40. Gisbert JP, Gisbert JL, Marcos S et al. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther 2006;24:1469-1474
41. Fujioka T, Yoshiiwa A, Okimoto T et al. Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects. J Gastroenterol 2007;42:3-6.
42. Chey WD, Wong BC. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 2007;102:1808-1825
43. Moayeddi P. Sequential regimens for Helicobacter pylori eradication. Lancet 2007;370:1010-1011
44. Sá nchez-Delgado J, Calvet X, Bujanda L et al. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol 2008;103:2220-2223
45. Oderda G, Rapa A, Bona G. A systematic review of Helicobacter pylori eradication schedules in children. Aliment Pharmacol Ther 2000;14 (Suppl 3):59-66.
46. Khurana R, Fishbach L, Chiba N et al. Meta-analysis: Helicobacter pylori eradication treatment efficacy in children. Aliment Pharmacol Ther 2007;25:523-536
47. Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med 2008;148:923-931